Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.21.73 extracted from

  • Kiessling, J.W.; Cines, D.B.; Higazi, A.A.; Armstead, W.M.
    Inhibition of integrin alphavbeta3 prevents urokinase plasminogen activator-mediated impairment of cerebrovasodilation after cerebral hypoxia/ischemia (2009), Am. J. Physiol. Heart Circ. Physiol., 296, H862-H867.
    View publication on PubMedView publication on EuropePMC

Cloned(Commentary)

Cloned (Comment) Organism
expression in S2 cells Sus scrofa

Molecular Weight [Da]

Molecular Weight [Da] Molecular Weight Maximum [Da] Comment Organism
50000
-
recombinant uPA, native PAGE Sus scrofa

Organism

Organism UniProt Comment Textmining
Sus scrofa
-
piglets
-

Purification (Commentary)

Purification (Comment) Organism
recombinant uPA from S2 cells by immunoaffinity chromatography Sus scrofa

Source Tissue

Source Tissue Comment Organism Textmining

Subunits

Subunits Comment Organism
monomer 1 * 50000, recombinant uPA, SDS-PAGE Sus scrofa

Synonyms

Synonyms Comment Organism
uPA
-
Sus scrofa
Urokinase plasminogen activator
-
Sus scrofa

General Information

General Information Comment Organism
malfunction urokinase plasminogen activator mediates impairment of hypercapnic and hypotensive cerebrovasodilation and pial artery dilation after cerebral hypoxia/ischemia, which is prevented by inhibition of integrin alphanubeta3, overview. Inhibition of uPA and integrin signaling may preserve cerebrohemodynamic control after hypoxia/ischemia Sus scrofa